The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
This is a sleeper added loads to my original holding few weeks back. The business and growth potential are great. 😊 One for the longterm.
Been away for some time from TRX, dabling in other sectors.
Decided to revist and not just intrigued but actually astonished at the state of the SP versus the actual company status, results etc.
SP dropped on the 19th! On release of what I can only honestly describe as remarkable results. Okay they didn't become post tax revenue positive (this time), but given the level of progress across the board, I am at a loss as to why the SP dropped and stayed down into the 61 region.
So decided it was time to start buying back in for the long term this time.
Is there 'anything' I'm missing about the company status, news etc that couldd keep this suppressed? Or is it just the state of the markets?
One thing that does 'concern' me is timhe state of the UK markets compared with the rise of the more extensive use of 'bots' for share dealing by major institutions. I've scan share charts across the board and it seems to me that there is an almost consistent 'attrtion' happening. This may be in my head but I'm beginning to consider whether the big institutions are (deliberately) adversely affecting the market via their 'bots' roll-out and implementation.
CONSPIRACY THEORISTS TO THE FRONT OF THE QUEUE PLEASE :-)
TRX are nominated in two categories:
Best Communication Award
Chief Executive of the Year
https://www.mediscience-event.co.uk/nominations-overview/
So frustrating - the sp is stuck on 61p - just don't understand given years of growth - guess they need to transition into true profitability not EBITA profitability but even so SP should be at £1 given all they have achieved - what is holding it back?
Yes I definitely voted in favour of all resolutions.
Very much support their focus and direction and agree re the web site - parts of it are out of date - looks sloppy.
I seem to remember getting something from IG. I just voted for everything , sorry I can't remember what the votes were for.
Basically , with 99+% of all resolutions passed we are just invited to vote to adhere to the law imo, we can make no difference.
In reply to the person who thinks we had movement today , we didn't. It was marked down 2.16 % the other day , the price on LES didn't change. It has been marked up the same today , the price hasn't changed.
Patience of a Saint required. Knowing when to sell will be my biggest problem.
If it spikes 40% which is quite possible , do I sell? It will get sold into , but will that be a trapdoor me to think the sp is falling off again.
Only to rerate by 200% within a week. That is the scenario I am sort of expecting.
When is another question.
Maybe I missed something, but I don't recall, nor can I find, any communications giving the resolutions at the AGM. The TRX website doesn't show anything that I can find, only AGMs up to 2023. Nothing on my dealing site either.
Has anyone received/seen anything? I'd like to know what the resolutions are (I'd like to have had an opportunity to vote on them!).
And on the subject of the company web site, if anyone from TRX is reading this, please bring it up to date.
Movement hooray!!!!
You read people touting a move to a US listing as the solution to all problems. Liquidity is better and there is multiple expansion. The multiple expansion will come and bite where it hurts when the inevitable contraction happens and the liquidity acts in both directions.
Better for TRX to stay where it is and wait and let it work itself out and for the patient to buy at bargain prices.
Totally understandable, but I would sit tight. The company is doing well. I think we all recognise that the suitability of the aim will be under review, and a Nasdaq listing (either joint or as an alternative) seems obvious once appropriate. It is operationally a US company after all. A takeover or being taken private (with a view to a US listing) are other potentials. Being taken private or sole Nasdaq listing has obvious drawbacks for uk PIs re ISAs
I have sold on third of my holding here. After three years I still showed a small loss but the market shows no interest in this company. I fear it might move to America before some large pharma snaps it up.
Risk adversion is becoming dire..... I still have the other two thirds because I can see nothing better to buy! I really hope something changes.
Yes markets in the doldrums - in other times the growth story here would have been richly rewarded. IMO it will happen soon enough - maybe a move from aim to nasdaq? The fact they can’t raise prices shows how competitive their market is so surely their being bought with less resulting less competition/economy of scale makes sense?
118 shares traded today in TRX , says it all really. Hopefully a takeover will be in the offing .
Before anyone says , I'm not suggesting we are listed on the FTSE ,AIM is worse!
The UK market is an ass, that's why many companies are leaving the UK. The FTSE doesn't even track the Dow now like it used to in the 90's. The FTSE is way below the valuation of the Dow.
The only time TRX will be valued correctly is if a takeover happens , otherwise UK hasn't a clue how to value anything.
I think that is the key point - I thought for many years they would have to raise again when they expanded and they have now ruled that out. Not only is that almost unique in an AIM share it also confirms management's confidence in themselves, their employees and the business
The report suggests that we are well undervalued ... well done Sherlock
Sorry, the No was about the £4 exit strategy
No
For three years I have held this share. So far I have nothing to show. The sp is moribund. However I do believe that the sun will come out tomorrow.... Its just a matter of living long enough to enjoy it. Talk over 2 pounds or four is just idle dreaming...Sometimes though dreams come true
I think most holders here would be delighted with a £2 share price even if that takes 2, 3, 4 years?
20% continual growth in revenues will make biotech funds sit up and take notice, just need one/two to start nibbling away at the shares for momentum to build.
Just glad we don't need to raise equity as numerous companies in the sector are having to take big haircuts on SP or choosing to delist entirely.
£4 exit strategy in 2 years? Is that what they've said? Not wanting to be confrontational, I haven't done much reading up on here, just genuinely curious :-)
The Board and the nature of the institutional investors know the value of what is being created. £4 exit strategy in 2years.
The Hardman report suggests a fair value of £1.77 per share!
A bit of a hidden gem this one. Have high hopes for this and hVIVO after getting my backside kicked with DeepVerge. Been here a long time and happy to wait a bit longer!!